The intravenous (IV) part of the phase IIb dose-finding PROCEED trial of bocunebart (Lu AG09222) met its primary endpoint in migraine prevention, demonstrating a statistically significant difference ...
NASA’s test run of its Artemis II countdown ran into problems Monday at Kennedy Space Center, scrapping any chance of the moonbound mission launching this month. Instead, the agency is targeting March ...
This is read by an automated voice. Please report any issues or inconsistencies here. In the midst of Grammy weekend, New Edition’s L.A. tour stop at the Kia Forum on Saturday was a forceful statement ...
The IRS issued a FATCA News and Information bulletin confirming that the International Data Exchange Service (IDES) is operational following a period of system unavailability. The bulletin also ...
The State Street SPDR S&P Semiconductor ETF (XSD) was launched on January 31, 2006, and is a passively managed exchange traded fund designed to offer broad exposure to the Technology - Semiconductors ...
State Street SPDR S&P Semiconductor ETF remains a buy, supported by strong momentum and a favorable technical setup. XSD outperformed the S&P 500 by 15 percentage points since July, with a 26% total ...
January 2026 marks the start of a new reporting era under the amended Common Reporting Standard (CRS). The OECD released the CRS XML Schema v3.0 and User Guide v4.0 in October 2024. Most jurisdictions ...
The 2025 Oklahoma high school football playoffs are here, and The Oklahoman is asking fans to vote on the team they think will win state championships in each classification. Will Rejoice Christian, ...
The CELEBRATE trial testing the novel injectable glycoprotein IIb/IIIa inhibitor zalunfiban ( Disaggpro; CeleCor Therapeutics) before hospital admission in STEMI patients has met its primary safety ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results